Tag Archives: Apotex

APO-Valsartan product recall

Apotex, in consultation with the TGA, is recalling all batches and strengths of the company’s supplied APO-Valsartan tablet blister packs due to the presence of trace elements of an impurity. The products being recalled comprise: • APO-Valsartan 40mg tablets (AUST R 185806). • APO-Valsartan 80mg tablets (AUST R 185814). • …

Read More »

ACCC clears merger

The Australian Competition and Consumer Commission has decided not to oppose the merger of generic pharmaceutical companies, Arrow and Apotex after finding the transaction “would not substantially lessen competition in any market”. In May 2018, Strides Pharma Science and Apotex announced their intention to merge Arrow Pharmaceuticals and Apotex Australia …

Read More »

TWC’s new initiatives

TerryWhite Chemmart’s largest conference ever, with more than 560 registered attendees, formally began in Sydney last Sunday (August 26) with the announcement of a new advisory group. The conference offered insights on future pharmacy and digital trends shared by an expert industry panel including Ebos CEO John Cullity and Apotex …

Read More »

Arrow and Apotex Australia to merge

Arrow Pharmaceuticals and Apotex have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations. The proposed merger, still subject to several conditions, including ACCC approval and due diligence, aims to create a sustainable platform for growth and development of the companies’ business interests in …

Read More »